Burkitt lymphoma
- Cells1
Trial sponsors
Company1 trialPhase 1/245 people
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
1 trialPhase 4300 people
Gustave Roussy, Cancer Campus, Grand Paris
2 trialsPhase 3300 people
6 trialsPhase 2764 people
4 trialsPhase 2216 people
3 trialsPhase 2179 people
Masonic Cancer Center, University of Minnesota
3 trialsPhase 293 people
2 trialsPhase 2120 people
Latest
Toxicology Reports
Fisetin targets phosphatidylinositol-3-kinase and induces apoptosis of human B lymphoma Raji cells
Experiments in human cellsFisetin
Scientific Reports
Aging alters genomic instability at endogenous mutation hotspots in mice
Experiments in miceDNA damage response